Skip to main content
NCBI home page
Antimicrobial Agents and Chemotherapy logoLink to Antimicrobial Agents and Chemotherapy
. 1988 Dec;32(12):1820–1824. doi: 10.1128/aac.32.12.1820

Safety and efficacy of topical norfloxacin versus tobramycin in the treatment of external ocular infections.

J A Jacobson 1, N B Call 1, E M Kasworm 1, M S Dirks 1, R B Turner 1
PMCID: PMC176025  PMID: 3072923

Abstract

Bacterial conjunctivitis appears to resolve more rapidly when treated with appropriate topical antimicrobial agents. In this multicenter, randomized, double-blind study of efficacy and safety, patients with presumed bacterial external eye infections were assigned to topical therapy with 0.3% norfloxacin or 0.3% tobramycin. A total of 120 patients were enrolled. Of the total, 65 had documented bacterial infections and were evaluable; 59 of these patients had bacterial conjunctivitis. All of the patients with documented infections were cured or improved regardless of the drug treatment regimen or in vitro susceptibility testing results. The most common bacteria isolated were Haemophilus influenzae, Streptococcus pneumoniae, alpha-hemolytic streptococci, Staphylococcus aureus, and Staphylococcus sp. No patients had serious adverse reactions attributed to their therapy. Norfloxacin ophthalmic solution seems to be a safe, effective, and appropriate agent for the treatment of bacterial external eye infections.

Full text

PDF
1820

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Brook I. Anaerobic and aerobic bacterial flora of acute conjunctivitis in children. Arch Ophthalmol. 1980 May;98(5):833–835. doi: 10.1001/archopht.1980.01020030827003. [DOI] [PubMed] [Google Scholar]
  2. Darougar S., Woodland R. M., Walpita P. Value and cost effectiveness of double culture tests for diagnosis of ocular viral and chlamydial infections. Br J Ophthalmol. 1987 Sep;71(9):673–675. doi: 10.1136/bjo.71.9.673. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Darrell R. W., Modak S. M., Fox C. L., Jr Norfloxacin and silver norfloxacin in the treatment of Pseudomonas corneal ulcer in the rabbit. Trans Am Ophthalmol Soc. 1984;82:75–91. [PMC free article] [PubMed] [Google Scholar]
  4. Gigliotti F., Hendley J. O., Morgan J., Michaels R., Dickens M., Lohr J. Efficacy of topical antibiotic therapy in acute conjunctivitis in children. J Pediatr. 1984 Apr;104(4):623–626. doi: 10.1016/s0022-3476(84)80566-1. [DOI] [PubMed] [Google Scholar]
  5. Gigliotti F., Williams W. T., Hayden F. G., Hendley J. O., Benjamin J., Dickens M., Gleason C., Perriello V. A., Wood J. Etiology of acute conjunctivitis in children. J Pediatr. 1981 Apr;98(4):531–536. doi: 10.1016/s0022-3476(81)80754-8. [DOI] [PubMed] [Google Scholar]
  6. Goldstein E. J., Citron D. M., Bendon L., Vagvolgyi A. E., Trousdale M. D., Appleman M. D. Potential of topical norfloxacin therapy. Comparative in vitro activity against clinical ocular bacterial isolates. Arch Ophthalmol. 1987 Jul;105(7):991–994. doi: 10.1001/archopht.1987.01060070135043. [DOI] [PubMed] [Google Scholar]
  7. Goldstein E. J. Norfloxacin, a fluoroquinolone antibacterial agent. Classification, mechanism of action, and in vitro activity. Am J Med. 1987 Jun 26;82(6B):3–17. doi: 10.1016/0002-9343(87)90612-7. [DOI] [PubMed] [Google Scholar]
  8. Jarudi N., Golden B., Hoyme J., Tyson M. D., Harter J. G. Comparison of antibiotic therapy in presumptive bacterial conjunctivitis. Am J Ophthalmol. 1975 May;79(5):790–794. doi: 10.1016/0002-9394(75)90738-2. [DOI] [PubMed] [Google Scholar]
  9. Leibowitz H. M., Pratt M. V., Flagstad I. J., Berrospi A. R., Kundsin R. Human conjunctivitis. II. Treatment. Arch Ophthalmol. 1976 Oct;94(10):1752–1756. doi: 10.1001/archopht.1976.03910040526011. [DOI] [PubMed] [Google Scholar]
  10. Leibowitz H. W., Pratt M. V., Flagstad I. J., Berrospi A. R., Kundsin R. Human conjunctivitis. I. Diagnostic evaluation. Arch Ophthalmol. 1976 Oct;94(10):1747–1749. doi: 10.1001/archopht.1976.03910040521010. [DOI] [PubMed] [Google Scholar]
  11. Perkins R. E., Kundsin R. B., Pratt M. V., Abrahamsen I., Leibowitz H. M. Bacteriology of normal and infected conjunctiva. J Clin Microbiol. 1975 Feb;1(2):147–149. doi: 10.1128/jcm.1.2.147-149.1975. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Salmon V. C., Turner R. B., Speranza M. J., Overall J. C., Jr Rapid detection of herpes simplex virus in clinical specimens by centrifugation and immunoperoxidase staining. J Clin Microbiol. 1986 Apr;23(4):683–686. doi: 10.1128/jcm.23.4.683-686.1986. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Shungu D. L., Tutlane V. K., Weinberg E., Gadebusch H. H. In vitro antibacterial activity of norfloxacin and other agents against ocular pathogens. Chemotherapy. 1985;31(2):112–118. doi: 10.1159/000238322. [DOI] [PubMed] [Google Scholar]
  14. Shungu D. L., Weinberg E., Gadebusch H. H. Tentative interpretive standards for disk diffusion susceptibility testing with norfloxacin (MK-0366, AM-715). Antimicrob Agents Chemother. 1983 Feb;23(2):256–260. doi: 10.1128/aac.23.2.256. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Wilhelmus K. R., Gilbert M. L., Osato M. S. Tobramycin in ophthalmology. Surv Ophthalmol. 1987 Sep-Oct;32(2):111–122. doi: 10.1016/0039-6257(87)90103-2. [DOI] [PubMed] [Google Scholar]

Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES